Product
Sodium Selenite
2 clinical trials
10 indications
Indication
Peripheral neuropathyIndication
Recurrent Ovarian CarcinomaIndication
Ovarian CancerIndication
Fallopian tube cancerIndication
Primary Peritoneal CarcinomaIndication
Prostate AdenocarcinomaIndication
Prostate CancerIndication
Recurrent Prostate CancerIndication
Multiple MyelomaIndication
PlasmacytomaClinical trial
Safety and Efficacy of High Dose Inorganic seLenium for Preventing Chemotherapy Induced pEripheral Neuropathy in platINUM Sensitive Recurrent Ovarian, Fallopian, Primary Peritoneal Cancer: Phase III Randomised Controlled TrialStatus: Active (not recruiting), Estimated PCD: 2023-04-30
Clinical trial
A Phase I Study Evaluating the Efficacy and Safety of Sodium Selenite in Combination With Palliative Radiation Therapy in Patients With Metastatic CancerStatus: Completed, Estimated PCD: 2018-05-01